Steffen Heeg

1.1k total citations
26 papers, 509 citations indexed

About

Steffen Heeg is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Steffen Heeg has authored 26 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 14 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Steffen Heeg's work include Pancreatic and Hepatic Oncology Research (9 papers), Cancer Research and Treatments (5 papers) and Telomeres, Telomerase, and Senescence (5 papers). Steffen Heeg is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Cancer Research and Treatments (5 papers) and Telomeres, Telomerase, and Senescence (5 papers). Steffen Heeg collaborates with scholars based in Germany, United States and Netherlands. Steffen Heeg's co-authors include Anil K. Rustgi, Maximilian Reichert, Shigetsugu Takano, Basil Bakir, Alexander von Werder, Oliver G. Opitz, Gregory P. Botta, Philip Hicks, Koushik K. Das and Michael Quante and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Steffen Heeg

24 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steffen Heeg Germany 11 273 240 110 87 62 26 509
Ahmed Guweidhi Germany 9 301 1.1× 304 1.3× 177 1.6× 104 1.2× 53 0.9× 12 643
Wataru Yasui Japan 10 272 1.0× 279 1.2× 121 1.1× 74 0.9× 55 0.9× 10 523
Laura López-Vicente Spain 4 265 1.0× 166 0.7× 69 0.6× 88 1.0× 42 0.7× 4 480
Nina Waldburger Germany 13 201 0.7× 149 0.6× 73 0.7× 119 1.4× 29 0.5× 19 456
George Koutsodontis Greece 12 356 1.3× 402 1.7× 65 0.6× 201 2.3× 24 0.4× 20 674
Yixiong Liu China 13 252 0.9× 157 0.7× 80 0.7× 123 1.4× 46 0.7× 38 547
Endong Chen China 13 279 1.0× 111 0.5× 132 1.2× 168 1.9× 31 0.5× 38 567
Leili Saeednejad Zanjani Iran 13 273 1.0× 201 0.8× 50 0.5× 114 1.3× 24 0.4× 37 497
Roxane M. Pommier France 11 224 0.8× 149 0.6× 87 0.8× 107 1.2× 18 0.3× 19 443
Jianchun Xu China 9 269 1.0× 213 0.9× 64 0.6× 98 1.1× 16 0.3× 15 500

Countries citing papers authored by Steffen Heeg

Since Specialization
Citations

This map shows the geographic impact of Steffen Heeg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Heeg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Heeg more than expected).

Fields of papers citing papers by Steffen Heeg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Heeg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Heeg. The network helps show where Steffen Heeg may publish in the future.

Co-authorship network of co-authors of Steffen Heeg

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Heeg. A scholar is included among the top collaborators of Steffen Heeg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Heeg. Steffen Heeg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goetze, Thorsten Oliver, Thomas J. Ettrich, Harald Schmalenberg, et al.. (2024). Paclitaxel/Ramucirumab versus Paclitaxel in 2nd-Line Therapy of Advanced Esophageal Squamous Cell Carcinoma: Randomized Phase II IKF-AIO-RAMOS Trial. Oncology Research and Treatment. 47(11). 549–560.
2.
3.
Goetze, Thorsten Oliver, Sylvie Lorenzen, Sven Arke Lang, et al.. (2021). Perioperative chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone in gallbladder carcinoma or in front of radical resection in BTC: The phase III GAIN trial.. Journal of Clinical Oncology. 39(3_suppl). TPS353–TPS353. 3 indexed citations
4.
Pape, Ulrich‐Frank, Stefan Kasper, Marianne Sinn, et al.. (2020). Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study. Cancers. 12(11). 3149–3149. 1 indexed citations
5.
Schauer, Franziska, Kristin Technau‐Hafsi, Johannes S. Kern, et al.. (2019). Esophageal lichen planus: towards diagnosis of an underdiagnosed disease. Scandinavian Journal of Gastroenterology. 54(10). 1189–1198. 23 indexed citations
6.
Pape, Ulrich‐Frank, Stefan Kasper, Marianne Sinn, et al.. (2019). Randomized phase II trial of the carboxylesterase (CES)-converted novel drug EDO-S7.1 in patients (pts) with advanced biliary tract cancers (BTC).. Journal of Clinical Oncology. 37(4_suppl). 264–264. 1 indexed citations
7.
Das, Koushik K., Steffen Heeg, Jason R. Pitarresi, et al.. (2018). ETV5 regulates ductal morphogenesis with Sox9 and is critical for regeneration from pancreatitis. Developmental Dynamics. 247(6). 854–866. 8 indexed citations
8.
Knoop, Richard, Hans-Juergen Richter-Schrag, Steffen Heeg, Jens Hoeppner, & Andreas Fischer. (2016). Radiofrequency ablation is a treatment option for early stages of verrucous esophageal carcinoma. VideoGIE. 1(4). 78–81.
9.
Heeg, Steffen, Koushik K. Das, Maximilian Reichert, et al.. (2016). ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer. Gastroenterology. 151(3). 540–553.e14. 49 indexed citations
10.
Takano, Shigetsugu, Maximilian Reichert, Basil Bakir, et al.. (2016). Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization. Genes & Development. 30(2). 233–247. 84 indexed citations
11.
Heeg, Steffen. (2015). Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer. Pharmacogenomics and Personalized Medicine. 8. 171–171. 1 indexed citations
12.
Heeg, Steffen, Maximilian Reichert, Shigetsugu Takano, et al.. (2015). 175 The Ets-Transcription Factor Etv1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer. Gastroenterology. 148(4). S–47. 7 indexed citations
13.
Queisser, Angela, et al.. (2013). Inhibition of telomerase induces alternative lengthening of telomeres during human esophageal carcinogenesis. Cancer Genetics. 206(11). 374–386. 28 indexed citations
14.
Reichert, Maximilian, Shigetsugu Takano, Johannes von Burstin, et al.. (2013). The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Genes & Development. 27(3). 288–300. 79 indexed citations
15.
Botta, Gregory P., Maximilian Reichert, Mauricio J. Reginato, et al.. (2013). ERK2-regulated TIMP1 Induces Hyperproliferation of K-RasG12D-Transformed Pancreatic Ductal Cells. Neoplasia. 15(4). 359–IN1. 17 indexed citations
16.
Reichert, Maximilian, Shigetsugu Takano, Steffen Heeg, et al.. (2013). Isolation, culture and genetic manipulation of mouse pancreatic ductal cells. Nature Protocols. 8(7). 1354–1365. 64 indexed citations
17.
18.
Werder, Alexander von, Steffen Heeg, Michael Quante, et al.. (2006). Inhibition of telomerase by mutant template telomerase RNA and anti-telomerase short interfering RNA induces ALT in immortalized human esophageal epithelial cells. Zeitschrift für Gastroenterologie. 44(8). 1 indexed citations
19.
Quante, Michael, Steffen Heeg, Alexander von Werder, et al.. (2005). Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis. Carcinogenesis. 26(11). 1879–1889. 14 indexed citations
20.
Quante, Michael, William C. Hahn, Hideki Harada, et al.. (2005). Creating oral squamous cancer cells: A cellular model of oral–esophageal carcinogenesis. Proceedings of the National Academy of Sciences. 102(43). 15599–15604. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed Guweidhi Breakdown of academic impact, for papers by Wataru Yasui Breakdown of academic impact, for papers by Laura López-Vicente Breakdown of academic impact, for papers by Nina Waldburger Breakdown of academic impact, for papers by George Koutsodontis Breakdown of academic impact, for papers by Yixiong Liu Breakdown of academic impact, for papers by Endong Chen Breakdown of academic impact, for papers by Leili Saeednejad Zanjani Breakdown of academic impact, for papers by Roxane M. Pommier Breakdown of academic impact, for papers by Jianchun Xu
Rankless by CCL
2026